Oruka Therapeutics prices upsized $700M public offering at $72.50 per share

Oruka Therapeutics (ORKA [https://seekingalpha.com/symbol/ORKA]) has announced an upsized public offering [https://seekingalpha.com/pr/20491699-oruka-therapeutics-announces-pricing-of-upsized-700-million-underwritten-public-offering] of 9.66M shares of common stock priced at $72.50 each, for an expected gross proceeds are about $700.4 million.

The underwriters have 30 days to purchase up to an additional 1.45M more shares at the public offering price, minus discounts and commissions.

All shares offered are being sold by Oruka.

The offering is set to close around April 30, 2026.

MORE ON ORUKA THERAPEUTICS

* Oruka Therapeutics, Inc. (ORKA) Discusses Interim Results From EVERLAST-A Study of ORKA-001 in Moderate to Severe Plaque Psoriasis Transcript [https://seekingalpha.com/article/4894740-oruka-therapeutics-inc-orka-discusses-interim-results-from-everlast-a-study-of-orkaminus-001]
* Oruka Therapeutics: 'Strong Buy' On Half-Life Extended IL-23p19 Inhibitor ORKA-001 [https://seekingalpha.com/article/4894718-oruka-therapeutics-strong-buy-on-half-life-extended-il-23p19-inhibitor-orka-001]
* Oruka Therapeutics: A Potential Future Psoriasis Play [https://seekingalpha.com/article/4874497-oruka-therapeutics-a-potential-future-psoriasis-play]
* Oruka Therapeutics GAAP EPS of -$0.45 [https://seekingalpha.com/news/4564048-oruka-therapeutics-gaap-eps-of-0_45]
* Seeking Alpha’s Quant Rating on Oruka Therapeutics [https://seekingalpha.com/symbol/ORKA/ratings/quant-ratings]